Gyala Therapeutics initiates phase I/IIa trial of a CAR-T cell therapy for acute leukaemias with limited treatment: Barcelona, Spain Wednesday, February 11, 2026, 18:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results